Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae  M. Ballestero-Téllez,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Angelo Berchieri Jr  Clinical Microbiology and Infection 
Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli  A. Couce, N. Alonso-Rodriguez, C. Costas,
Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,
Gut bacterial microbiota and obesity
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Migrant health—a cause for concern?
Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1?  J. Dobias, L. Poirel, P. Nordmann 
Easy synergism for colistin-resistant KPC-producing Klebsiella pneumoniae: the E-test with supplemented agar  E. Tagliaferri, C. Tascini, A. Leonildi,
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries  J.A. Otter, N.T. Mutters, E. Tacconelli, A.
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus  S. Croes, P.S.
Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli  R.A. Hickman, D. Hughes,
Angelo Berchieri Jr  Clinical Microbiology and Infection 
In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii  Y. Smani, R. López-Rojas, J. Dominguez-Herrera,
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and.
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Results from a mathematical model for human monocytic ehrlichiosis
P. Moreillon, J.M. Entenza  Clinical Microbiology and Infection 
D.E. Low  Clinical Microbiology and Infection 
Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia—a 7-year individual and population-based analysis  A. Egli,
Do we need new antibiotics?
Correlation of quinolone resistance levels and differences in basal and quinolone- induced expression from three qnrA-containing plasmids  J.M. Rodríguez-Martínez,
E.C. Böttger  Clinical Microbiology and Infection 
Unveiling the molecular basis of antimicrobial resistance in Staphylococcus aureus from the Democratic Republic of the Congo using whole genome sequencing 
Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin- clavulanate and piperacillin-tazobactam with extended-spectrum.
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis  R. Diaz, V. Afreixo,
Aerococcus: an increasingly acknowledged human pathogen
G. Kronvall  Clinical Microbiology and Infection 
Elements of design: the knowledge on which we build
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole.
Metagenomics and probiotics
Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy  J. Findlay, A. Hamouda,
W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
Jacques Sirot, Patrice Courvalin, Claude-James Soussy 
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China  J.D. Sun, S.F. Huang, S.S.
Activity of cefepime and carbapenems in experimental pneumonia caused by porin- deficient Klebsiella pneumoniae producing FOX-5 β-lactamase  C. Pichardo,
T. Schön, P. Miotto, C.U. Köser, M. Viveiros, E. Böttger, E. Cambau 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae  Y. Harada,
C. Gagliotti, L. Nobilio, M.L. Moro 
M.B. Kerrn, N. Frimodt-Møller, F. Espersen 
Clinical Microbiology and Infection
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae  I. Gustafsson, O. Cars  Clinical Microbiology.
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients 
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
Endotoxin release from Escherichia coli after exposure to tobramycin: dose-dependency and reduction in cefuroxime-induced endotoxin release  J. SjöUlin,
Virology: a scientific discipline facing new challenges
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia—a 7-year individual and population-based analysis  A. Egli,
Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods  C. Muller-Serieys,
High prevalence of mutators among Enterobacter cloacae nosocomial isolates and their association with antimicrobial resistance and repetitive detection 
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae  M. Ballestero-Téllez, F. Docobo-Pérez, J.M. Rodríguez-Martínez, M.C. Conejo, M.S. Ramos-Guelfo, J. Blázquez, J. Rodríguez-Baño, A. Pascual  Clinical Microbiology and Infection  Volume 23, Issue 5, Pages 325-331 (May 2017) DOI: 10.1016/j.cmi.2016.12.022 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Bland–Altman analysis of agreement between agar dilution (104 CFU/spot) and broth microdilution performed with (a) low inoculum (105 CFU/mL, i.e. 104 CFU/well) similar to the agar dilution method or (b) standard inoculum (2 × 105 to 8 × 105 CFU/mL, i.e. 2 × 104 to 8 × 104 CFU/well). The differences of the log2-transformed MICs obtained by agar dilution and broth microdilution are plotted against their mean MIC values. The solid line represents the mean of the differences, the dotted lines indicate the lower and upper limits of the 95% CI. Clinical Microbiology and Infection 2017 23, 325-331DOI: (10.1016/j.cmi.2016.12.022) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Fosfomycin mutant frequency at different concentrations of 21 Escherichia coli (MIC=1mg/L) and 21 Klebsiella pneumoniae (MIC=16mg/L) clinical isolates. Horizontal bars and whiskers represent the mean and SD, respectively. Open grey circles denote each independent result. Clinical Microbiology and Infection 2017 23, 325-331DOI: (10.1016/j.cmi.2016.12.022) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 3 Subpopulation growth monitoring over time, at different initial bacterial inocula. Total bacterial population (no fosfomycin) is shown by red lines. Resistant subpopulations able to grow at 4 mg/L (blue lines) and 8 mg/L (green lines) of fosfomycin (4×and 8×MIC) are shown for Ec42, Ec148, Ec162, Ec271, Ec2974 and Escherichia coli ATCC 25922 strains (all with MIC=1mg/L). Each line represents the growth of a single experiment. Experiments were carried out in quadruplicate using the same overnight inoculum. Clinical Microbiology and Infection 2017 23, 325-331DOI: (10.1016/j.cmi.2016.12.022) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions